Sprouty4 is epigenetically upregulated in human colorectal cancer
Sprouty4 (SPRY4) has been frequently reported as a tumor suppressor and is therefore downregulated in various cancers. For the first time, we report that SPRY4 is epigenetically upregulated in colorectal cancer (CRC). In this study, we explored DNA methylation and hydroxymethylation levels of SPRY4...
Main Authors: | Alexei J. Stuckel, Shuai Zeng, Zhen Lyu, Wei Zhang, Xu Zhang, Urszula Dougherty, Reba Mustafi, Tripti Khare, Qiong Zhang, Trupti Joshi, Marc Bissonnette, Sharad Khare |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2022.2145068 |
Similar Items
-
Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers
by: Alexei J. Stuckel, et al.
Published: (2021-10-01) -
Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer
by: Alexei J. Stuckel, et al.
Published: (2020-02-01) -
Effects of sprouty4 protein on keratinocyte proliferation and differentiation
by: Yu-qi HUANG, et al.
Published: (2020-06-01) -
Sprouty3, but Not Sprouty1, Expression Is Beneficial for the Malignant Potential of Osteosarcoma Cells
by: Anna Zita Mehira Kamptner, et al.
Published: (2021-11-01) -
Macrophage Sprouty4 deficiency diminishes sepsis-induced acute lung injury in mice
by: Rong Chen, et al.
Published: (2022-12-01)